The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by half among women in the VOICE trial who used a vaginal gel containing the antiretroviral (ARV) drug tenofovir regularly, according to researchers from ...
Oct 28, 2014
0
0
Scientists at Queen's University Belfast have made a breakthrough in the fight against the most resistant hospital superbugs.
Aug 19, 2014
0
0
A gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer reduced the growth of cancer cells to the same degree as the drug taken in oral form but with fewer side effects that deter some women ...
Jul 15, 2014
0
0
Testosterone replacement therapy may help older men who have limited mobility and low testosterone improve their aerobic capacity and lessen its decline with age, new research finds. The results were presented in a poster ...
Jun 23, 2014
0
0
Population Council scientists and their partners have found that their proprietary microbicide gel is safe, stable, and can prevent the transmission of multiple sexually transmitted infections (STIs) in both the vagina and ...
Apr 17, 2014
0
0
(HealthDay)—Spurred by a recent report that popular testosterone treatments might raise men's heart risk, the U.S. Food and Drug Administration says it now plans a review of the therapies' safety.
Feb 3, 2014
0
0
US federal regulators said Friday they were investigating products containing testosterone after recent studies suggested a higher risk of strokes and heart attacks in men being treated with the hormone.
Feb 1, 2014
0
0
(HealthDay)—Testosterone therapy—widely advertised as a way to help men improve a low sex drive and reclaim diminished energy—might raise the risk of heart attack, according to new research.
Jan 29, 2014
0
0
(HealthDay)—A sealant gel to prevent fluid leakage after cataract surgery has been approved by the U.S. Food and Drug Administration.
Jan 10, 2014
0
0
Taking an important step toward the development of a product to prevent HIV infections associated with unprotected anal sex, researchers today announced the launch of a global Phase II clinical trial of a potential rectal ...
Oct 2, 2013
0
0
